216 related articles for article (PubMed ID: 37442413)
41. APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability.
Kawale AS; Ran X; Patel PS; Saxena S; Lawrence MS; Zou L
Sci Adv; 2024 Jan; 10(3):eadk2771. PubMed ID: 38241374
[TBL] [Abstract][Full Text] [Related]
42. The double-domain cytidine deaminase APOBEC3G is a cellular site-specific RNA editing enzyme.
Sharma S; Patnaik SK; Taggart RT; Baysal BE
Sci Rep; 2016 Dec; 6():39100. PubMed ID: 27974822
[TBL] [Abstract][Full Text] [Related]
43. Nuclear Magnetic Resonance Structure of the APOBEC3B Catalytic Domain: Structural Basis for Substrate Binding and DNA Deaminase Activity.
Byeon IJ; Byeon CH; Wu T; Mitra M; Singer D; Levin JG; Gronenborn AM
Biochemistry; 2016 May; 55(21):2944-59. PubMed ID: 27163633
[TBL] [Abstract][Full Text] [Related]
44. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
Ito F; Fu Y; Kao SA; Yang H; Chen XS
J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
[TBL] [Abstract][Full Text] [Related]
45. Identification of the yeast cytidine deaminase CDD1 as an orphan C-->U RNA editase.
Dance GS; Beemiller P; Yang Y; Mater DV; Mian IS; Smith HC
Nucleic Acids Res; 2001 Apr; 29(8):1772-80. PubMed ID: 11292850
[TBL] [Abstract][Full Text] [Related]
46. Single-Molecule Force Spectroscopy Studies of APOBEC3A-Single-Stranded DNA Complexes.
Shlyakhtenko LS; Dutta S; Li M; Harris RS; Lyubchenko YL
Biochemistry; 2016 Jun; 55(22):3102-6. PubMed ID: 27182892
[TBL] [Abstract][Full Text] [Related]
47. Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.
Goila-Gaur R; Khan MA; Miyagi E; Kao S; Strebel K
Retrovirology; 2007 Aug; 4():61. PubMed ID: 17727729
[TBL] [Abstract][Full Text] [Related]
48. Distinguishing preferences of human APOBEC3A and APOBEC3B for cytosines in hairpin loops, and reflection of these preferences in APOBEC-signature cancer genome mutations.
Butt Y; Sakhtemani R; Mohamad-Ramshan R; Lawrence MS; Bhagwat AS
Nat Commun; 2024 Mar; 15(1):2369. PubMed ID: 38499553
[TBL] [Abstract][Full Text] [Related]
49. Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A.
Aynaud MM; Suspène R; Vidalain PO; Mussil B; Guétard D; Tangy F; Wain-Hobson S; Vartanian JP
J Biol Chem; 2012 Nov; 287(46):39182-92. PubMed ID: 22977230
[TBL] [Abstract][Full Text] [Related]
50. Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association.
Niewiadomska AM; Tian C; Tan L; Wang T; Sarkis PT; Yu XF
J Virol; 2007 Sep; 81(17):9577-83. PubMed ID: 17582006
[TBL] [Abstract][Full Text] [Related]
51. Crystal structure of APOBEC3A bound to single-stranded DNA reveals structural basis for cytidine deamination and specificity.
Kouno T; Silvas TV; Hilbert BJ; Shandilya SMD; Bohn MF; Kelch BA; Royer WE; Somasundaran M; Kurt Yilmaz N; Matsuo H; Schiffer CA
Nat Commun; 2017 Apr; 8():15024. PubMed ID: 28452355
[TBL] [Abstract][Full Text] [Related]
52. Improvement of C-to-U RNA editing using an artificial MS2-APOBEC system.
Li J; Fan G; Sakari M; Tsukahara T
Biotechnol J; 2024 Jan; 19(1):e2300321. PubMed ID: 38010373
[TBL] [Abstract][Full Text] [Related]
53. RNA editing by base deamination: more enzymes, more targets, new mysteries.
Gerber AP; Keller W
Trends Biochem Sci; 2001 Jun; 26(6):376-84. PubMed ID: 11406411
[TBL] [Abstract][Full Text] [Related]
54. Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity.
Pautasso S; Galitska G; Dell'Oste V; Biolatti M; Cagliani R; Forni D; De Andrea M; Gariglio M; Sironi M; Landolfo S
J Virol; 2018 Oct; 92(19):. PubMed ID: 30045985
[TBL] [Abstract][Full Text] [Related]
55. Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots.
Jalili P; Bowen D; Langenbucher A; Park S; Aguirre K; Corcoran RB; Fleischman AG; Lawrence MS; Zou L; Buisson R
Nat Commun; 2020 Jun; 11(1):2971. PubMed ID: 32532990
[TBL] [Abstract][Full Text] [Related]
56. BE-FLARE: a fluorescent reporter of base editing activity reveals editing characteristics of APOBEC3A and APOBEC3B.
Coelho MA; Li S; Pane LS; Firth M; Ciotta G; Wrigley JD; Cuomo ME; Maresca M; Taylor BJM
BMC Biol; 2018 Dec; 16(1):150. PubMed ID: 30593278
[TBL] [Abstract][Full Text] [Related]
57. APOBEC3s: DNA-editing human cytidine deaminases.
Silvas TV; Schiffer CA
Protein Sci; 2019 Sep; 28(9):1552-1566. PubMed ID: 31241202
[TBL] [Abstract][Full Text] [Related]
58. The DNA damage induced by the Cytosine Deaminase APOBEC3A Leads to the production of ROS.
Niocel M; Appourchaux R; Nguyen XN; Delpeuch M; Cimarelli A
Sci Rep; 2019 Mar; 9(1):4714. PubMed ID: 30886206
[TBL] [Abstract][Full Text] [Related]
59. Cellular APOBEC3A deaminase drives mutations in the SARS-CoV-2 genome.
Nakata Y; Ode H; Kubota M; Kasahara T; Matsuoka K; Sugimoto A; Imahashi M; Yokomaku Y; Iwatani Y
Nucleic Acids Res; 2023 Jan; 51(2):783-795. PubMed ID: 36610792
[TBL] [Abstract][Full Text] [Related]
60. Her2 amplification, Rel-A, and Bach1 can influence APOBEC3A expression in breast cancer cells.
Dennis M; Hurley A; Bray N; Cordero C; Ilagan J; Mertz TM; Roberts SA
PLoS Genet; 2024 May; 20(5):e1011293. PubMed ID: 38805570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
